Variant report
| Variant | nsv236994 |
|---|---|
| Chromosome Location | chr3:24918855-24919701 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:24 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs150327050 | chr3:24919003-24919004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 2 | rs548704987 | chr3:24919040-24919041 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs571827395 | chr3:24919047-24919048 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs576351030 | chr3:24919053-24919054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs77415150 | chr3:24919062-24919063 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs528339579 | chr3:24919095-24919096 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs570480375 | chr3:24919109-24919110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs548393440 | chr3:24919134-24919135 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs200428189 | chr3:24919171-24919172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs552972650 | chr3:24919186-24919187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs115655805 | chr3:24919190-24919191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs12493197 | chr3:24919200-24919201 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 13 | rs144362251 | chr3:24919206-24919207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs139010006 | chr3:24919218-24919219 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs545057747 | chr3:24919285-24919286 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs575412890 | chr3:24919289-24919290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs185414221 | chr3:24919296-24919297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs141178810 | chr3:24919309-24919310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs190216882 | chr3:24919321-24919322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs541737331 | chr3:24919364-24919365 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs559780112 | chr3:24919365-24919366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs565406959 | chr3:24919378-24919379 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs542061238 | chr3:24919388-24919389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs563501152 | chr3:24919399-24919400 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Variant related diseases (count:69)
| Disease | PMID | Source |
|---|---|---|
| Esophageal squamous carcinoma | 18405350 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Neuroblastoma | 17327916 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Neuroblastoma | 18923191 | CNVD |
| Colorectal cancer | 21297112 | CNVD |
| Lynch syndrome | 18415027 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Urothelial carcinoma | 18382360 | CNVD |
| Melanoma | 18172304 | CNVD |
| Cervical cancer | 21062161 | CNVD |
| Hirschsprung''s Disease | 21712996 | CNVD |
| head and neck squamous cell carcinoma | 17671120 | CNVD |
| Insulin resistance | 16721378 | CNVD |
| Neuroblastoma | 18664255 | CNVD |
| Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
| Multiple myeloma | 17077331 | CNVD |
| Oral squamous cell carcinoma | 17134496 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Neuroblastoma | 21484798 | CNVD |
| Non-small cell lung cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Oral cancer | 19627613 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Epithelial cancer | 22065749 | CNVD |
| Acute lymphoblastic leukemia | 21390130 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Basal cell lymphoma | 21115979 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Pancreatic endocrine tumor | 20981439 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Oral cancer | 21386901 | CNVD |
| Cutaneous squamous cell carcinomas | 19131950 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Basal cell lymphoma | 17053054 | CNVD |
| Esophageal cancer | 21851588 | CNVD |
| Uveal melanoma | 21693616 | CNVD |
| Retinoblastoma | 21504564 | CNVD |
| T-cell prolymphocytic leukemia | 17713554 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Renal cell carcinoma | 21668985 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Thoracic aortic aneurysm | 21092924 | CNVD |
| Lung cancer | 20668451 | CNVD |
| Breast cancer | 20668451 | CNVD |
| Cancer | 20668451 | CNVD |
| Ovarian cancer | 20668451 | CNVD |
| Pancreas cancer | 20668451 | CNVD |
| Prostate cancer | 20668451 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Esophageal cancer | 20955586 | CNVD |
| Myeloproliferative neoplasm | 20015882 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Squamous cell cancer | 20885788 | CNVD |
| Breast cancer | 17133270 | CNVD |
| Uveal melanoma | 20484589 | CNVD |
| Autism | 22495311 | CNVD |
| Melanoma | 20688739 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr3:24919000-24919400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
